Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Some people using minoxidil for hair loss developed an allergic skin reaction, often related to an ingredient that helps minoxidil work better.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Permanent hair dye may cause total hair loss.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Quercetin may help improve skin conditions in cats with Feline Atopic Skin Syndrome.

Acitretin may cause salivary gland inflammation.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Dupilumab for eczema may cause hair loss.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.